Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women

被引:47
作者
Khadang, Baharak
Fattahi, Mohammad Javad
Talei, Abdolrasol
Dehaghani, Alamtaj Samsami
Ghaderi, Abbas
机构
[1] Shiraz Univ Med Sci, Shiraz Inst Canc Res, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Surg, Shiraz, Iran
[3] Shiraz Univ Med Sci, Dept Obstet & Gynecol, Shiraz, Iran
[4] Shiraz Univ Med Sci, Dept Immunol, Shiraz, Iran
关键词
D O I
10.1016/j.cancergencyto.2006.09.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the most common female malignancy worldwide. Despite the high incidence of sporadic cases, the rate of familial breast cancer is low. The tumor suppressor gene TP53 (alias p53), located on chromosome 17, has been involved in various malignancies. Mutations in codon 72 of TP53 have been studied in breast cancer and most solid tumors. For study of polymorphisms and allele frequency, 221 female patients with sporadic breast cancer and 205 healthy blood donors as control group were recruited. DNA from peripheral blood mononuclear cells was extracted and amplified using allele-specific polymerase chain reaction. Frequency of homozygotic arginine at codon 72 was 37.6% in patients and 36.6% in controls, for homozygotic proline it was 13.1 and 19.5%, and for heterozygotic Arg/Pro it was 49.3 and 43.9%, respectively. No significant difference was found between patients and controls regarding allele frequencies. Mutation in codon 72 of TP53 gene was not associated with breast cancer in Iranian patients. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:38 / 42
页数:5
相关论文
共 49 条
[1]  
AGORASTOS T, 2002, EUR J CANCER PREV, V13, P277
[2]  
Bautista S, 1997, PATHOL BIOL, V45, P882
[3]   Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer [J].
Berns, EMJJ ;
van Staveren, IL ;
Look, MP ;
Smid, M ;
Klijn, JGM ;
Foekens, JA .
BRITISH JOURNAL OF CANCER, 1998, 77 (07) :1130-1136
[4]  
Buyru N, 2003, ONCOL REP, V10, P711
[5]   Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6 [J].
Crook, T ;
Ludwig, RL ;
Marston, NJ ;
Willkomm, D ;
Vousden, KH .
VIROLOGY, 1996, 217 (01) :285-292
[6]  
Dokianakis DN, 2000, INT J MOL MED, V5, P405
[7]   P53: guardian and suppressor of longevity? [J].
Donehower, LA .
EXPERIMENTAL GERONTOLOGY, 2005, 40 (1-2) :7-9
[8]   The codon 72 polymorphic variants of p53 have markedly different apoptotic potential [J].
Dumont, P ;
Leu, JIJ ;
Della Pietra, AC ;
George, DL ;
Murphy, M .
NATURE GENETICS, 2003, 33 (03) :357-365
[9]   High risk HPV types in southern Iranian patients with cervical cancer [J].
Farjadian, S ;
Asadi, E ;
Doroudchi, M ;
Dehaghani, AS ;
Tabei, SZ ;
Kumar, VP ;
Ghaderi, A .
PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (02) :121-125
[10]  
GOLDHIRSCH A, 2000, TXB MED ONCOLOGY, P137